[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342069-105":59,"doc-detail-342069-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","golm1-promotes-prostate-cancer-progression-via-interaction-with-psmd1-and-enhancing-ar-driven-transcriptional-activation","GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR-driven transcriptional activation","","Aberrant transcriptional activation of the androgen receptor (AR) drives prostate cancer (PCa) in both initial and androgen-independent stages. This study identifies Golgi membrane protein 1 (GOLM1) as a regulator of AR-driven transcriptional activity during PCa progression. Using local clinical and TCGA datasets, the work links GOLM1 with AR target genes and shows GOLM1 enhances their expression. Mass spectrometry and Co-IP reveal GOLM1 interaction with PSMD1, a 19S regulatory complex component of the 26S proteasome. By binding PSMD1, GOLM1 increases ubiquitin-proteasome activity, facilitating AR transcriptional activation and PCa progression, suggesting therapeutic targeting potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/golm1-promotes-prostate-cancer-progression-via-interaction-with-psmd1-and-enhancing-ar-driven-transcriptional-activation/342069/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/golm1-promotes-prostate-cancer-progression-via-interaction-with-psmd1-and-enhancing-ar-driven-transcriptional-activation/342069.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does AR transcriptional activation play in prostate cancer progression?","Question",{"text":112,"@type":113},"The document states that aberrant AR-driven transcriptional activation is a predominant cause of prostate cancer in both early and androgen-independent stages, contributing to progression toward castration-resistant prostate cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is GOLM1 connected to AR signaling in this study?",{"text":117,"@type":113},"The study reports an association between GOLM1 and AR target genes using local clinical and TCGA data, and demonstrates that GOLM1 enhances the expression of AR target genes.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports the interaction between GOLM1 and PSMD1?",{"text":121,"@type":113},"Mass spectrometry and Co-IP analysis are used to show that GOLM1 interacts with PSMD1, described as part of the 19S regulatory complex in the 26S proteasome.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342069,1790144731,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Received: 20 May 2024 | Revised: 20 October 2024 | Accepted: 22 October 2024  \n\n| DOI: 10. 1111/jcmm.70186 |  |\n| --- | --- |\n| OR I G I NAL ART I C L E\u003Cbr>| |\n| GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR-driven transcriptional activation\u003Cbr>Guang Yan1,2 | Tianhang Zhu1 | Jiawei Zhou1 | Xia Li3 | Zonghua Wen4 | Bahaerguli Miuhuitijiang1 | Zhiyong Zhang1 | Yuejun Du1 | Chengyao Li5 | Xiaojun Shi1 | Wanlong Tan1 \u003Cbr>1Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China\u003Cbr>2Department of Andrology, Shanghai Seventh People's Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China\u003Cbr>3State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, Shaanxi, China\u003Cbr>4Department of Pathology, Shenzhen University General Hospital, Shenzhen, China\u003Cbr>5Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China |  |\n| Correspondence\u003Cbr>Wanlong Tan and Xiaojun Shi, Department of Urology, Nanfang Hospital, Southern Medical University, No. 1838, North Guangzhou Avenue Guangzhou, Guangdong 510515, China.\u003Cbr>Email: tanwanlongdoctor@163 . com, [tanwanlong@gmail.com](tanwanlong@gmail.com) and [13395638975@163.com](13395638975@163.com)\u003Cbr>Chengyao Li, School of Laboratory Medicine and Biotechnology, Southern Medical University, No. 1838, North Guangzhou Avenue Guangzhou, Guangdong 510515, China.\u003Cbr>Email: [chengyaoli@hotmail.com](chengyaoli@hotmail.com)\u003Cbr>Funding information\u003Cbr>Supported by Pudong Institute of Clinical Chinese Medicine, Grant/Award Number: YC-2023-0609; The “Fourteenth FiveYear Plan” Traditional Chinese Medicine Specialty Project for the Construction of Andrology Departments in TCM, Grant/ Award Number: ZYTSZK1-4; National Natural Science Foundation of China, Grant/Award Number: 82073162 and 82372867; China Postdoctoral Science Foundation, Grant/Award Number:\u003Cbr>2022M711520 | \u003Cbr>Abstract\u003Cbr>Aberrant transcriptional activation of the androgen receptor (AR) is a predominant cause of prostate cancer (PCa), including both in the initial and androgen-independent stages. Our study highlights Golgi membrane protein 1 (GOLM1) as a key regulator of AR-driven transcriptional activity in PCa progression. Utilizing local clinical data and TCGA data, we have established a robust association between GOLM1 and AR target genes, and further demonstrated that GOLM1 can enhance the expression of AR target genes. We discovered that GOLM1 interacts with PSMD1, a component of the 19S regulatory complex in the 26S proteasome, using mass spectrometry and Co-IP analysis. It is well known that ubiquitin-proteasome plays a vital role in AR expression and transcriptional regulation. Our findings demonstrate that GOLM1 enhances ubiquitin proteasome activity by binding to PSMD1, thereby facilitating AR-driven transcriptional activity and PCa progression. These results indicate that GOLM1 and its associated proteins may become potential therapeutic targets for PCa characterized by dysregulated AR-driven transcriptional activation.\u003Cbr>K E Y WO R D S\u003Cbr>AR, GOLM1, prostate cancer, PSMD1, UPS |\n| Guang Yan, Tianhang Zhu, and Jiawei Zhou contributed equally to this work. |  |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2024 The Author(s) . Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. |  |\n\nJ Cell Mol Med. 2024;28:e70186 .  \n[https://doi.org/10.1111/jcmm.70186](https://doi.org/10.1111/jcmm.70186)  \n[wileyonlinelibrary.com/journal/jcmm](wileyonlinelibrary.com/journal/jcmm)  \n1 of 15  \n1 | INTRODUCTION  \nProstate cancer (PCa) is the ","cbCaintpXyRuPyQd","https://ap.wps.com/l/cbCaintpXyRuPyQd","pdf",15169565,15,"English","# Abstract\n## Introduction","[{\"question\":\"What role does AR transcriptional activation play in prostate cancer progression?\",\"answer\":\"The document states that aberrant AR-driven transcriptional activation is a predominant cause of prostate cancer in both early and androgen-independent stages, contributing to progression toward castration-resistant prostate cancer.\"},{\"question\":\"How is GOLM1 connected to AR signaling in this study?\",\"answer\":\"The study reports an association between GOLM1 and AR target genes using local clinical and TCGA data, and demonstrates that GOLM1 enhances the expression of AR target genes.\"},{\"question\":\"What experimental evidence supports the interaction between GOLM1 and PSMD1?\",\"answer\":\"Mass spectrometry and Co-IP analysis are used to show that GOLM1 interacts with PSMD1, described as part of the 19S regulatory complex in the 26S proteasome.\"}]","GOLM1 promotes prostate cancer progression via interaction with PSMD1 and enhancing AR-driven transcriptional activation | PDF",1790045020,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45783d87f68b7da7eaa3170f1771bcb1.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7baf42d610ba8528f06fbd9bc93d01f.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58c95cf72703366a32b6fd31e9477533.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc6d3c3b44a423db64953908dbb03a46.webp",980,1287]